LYCOS RETRIEVER 
Tinnitus: Tinnitus Clinic
built 296 days ago
Tinnitus is a common phenomenon that affects about 17% of the general population and about 33% of the elderly. Until recently tinnitus did not receive sufficient attention, both in clinical practice and in research. While the perception of tinnitus is very real, there is no external sound corresponding to the patients' perception of sound; ... tinnitus can be classified as a phantom auditory perception. Consequently there is no objective measurement of tinnitus.
Source:
Following extensive tinnitus research and clinical trials, the Neuromonics Tinnitus Treatment results show significantly reduced awareness and tinnitus disturbance for up to 90% of participants. Additionally, the participants reported improved relaxation, sleep and quality of life.
Source:
The Neuromonics Tinnitus Treatment [H]as been developed and refined over more than 10 years of research and clinical practice. Its success has been demonstrated in clinical trials involving hundreds of people with tinnitus and reduced sound tolerance.
Source:
BACKGROUND: chronic tinnitus is a disabling, almost untreatable, condition usually accompanied by psychiatric distress. In patients with complex neuropsychiatric diseases as chronic pain, with whom tinnitus shares pathophysiological similarities, placebo effects may be pronounced. Moreover, it may be difficult to distinguish actual rTMS-induced clinical benefits beyond placebo effects in neuropsychiatric patients. METHODS: 16 patients with chronic tinnitus underwent a randomized, double-blind, cross-over, placebo controlled trial of 1 Hz rTMS (120% of motor threshold; 1200 stimuli/day for 5 days) of the left temporoparietal region. Patients were screened for psychiatric comorbidity; additionally, anxiety and depression were monitored throughout the study. Moreover, an original placebo rTMS procedure produced the same activation of ipsilateral face muscles (a condition which may per se change tinnitus subjective rating) of the real rTMS.
Source:
Zinc supplements have been used to treat people who had both tinnitus and hearing loss (usually age-related). Of those who had initially low blood levels of zinc, about 25% experienced an improvement in tinnitus after taking zinc (90–150 mg per day for three to six months).2 Such large amounts of zinc should be monitored by a doctor. Two controlled clinical trials3 4 found no benefit from zinc supplementation (66 mg per day in one double-blind trial) in people with tinnitus. However, participants in these studies were not zinc deficient. Preliminary research suggests that zinc supplementation is only helpful for tinnitus in people who are zinc deficient.5 A doctor can measure blood levels of zinc.
Source:
Background: Chronic tinnitus is a frequent symptom presentation in clinical practice. No drug treatment to date has shown itself to be effective. The aim of the present study was to investigate the effects of cognitive behavioural therapy and meditation in tinnitus sufferers.Methodology: Patients were selected from a dedicated tinnitus clinic in the Welsh Hearing Institute. A waiting list control design was used. Twenty-five chronic tinnitus sufferers were consecutively allocated to two groups, one receiving a cognitive behavioural therapy/meditation intervention of four one hour sessions with the other group waiting three months and subsequently treated in the same way, thereby acting as their own control. The main outcome was measured using the Hallam tinnitus questionnaire.
Source:
MORE ABOUT
Tinnitus Clinic